Abstract
Objective
Aim of this study was to show the change of diameter of mammary ducts in relation to polycystic ovaries disease.
Design
Women who took part were divided into two groups- the first with polycystic ovaries disease and another second group with no such disease.
Method
To both groups a series of laboratory, clinical and ultrasound (u/s) exams were used to diagnose polycystic ovaries disease. Furthermore u/s measurement of mammary ducts was used to define the diameter.
Results
In women with polycystic ovaries disease u/s showed an increase in diameter of mammary ducts whereas in the second group we didn’t observe such finding.
Conclusion
Our study showed that there seems to be a strong relation between the increased diameter of the main terminal lactiferous ducts- the polycystic configuration of the ovaries and the hormonal levels.
Similar content being viewed by others
References
Marx TL, Mehta AE (2003) Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve Clin J Med 70:31–33,36–41, 45
Slowey MJ (2001) Polycystic ovary syndrome: new perspective on an old problem. South Med J 94:190–196
Homburg R (1996) Polycystic ovary syndrome- from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 11:29–39
Marshall K (2001) Polycystic ovary syndrome : clinical considerations. Altern Med Rev 6:272–292
Yen SS, Vela P, Rankin J (1970) Innappopriate secretion of follicle-stimulaying hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 30:435–442
D’Amelio R, et al (2001) Association between polycystic ovary and fibrocystic breast disease. Gynecol Obstet Invest 51:134–137
Milliken, et al (2002) Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology 143:3671–3680
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Panaritis, V., Despotidis, P. & Kyriakidis, A. Diameter of mammary terminal ducts as an additional tool in evaluation of women with polycystic ovarium disease. Arch Gynecol Obstet 270, 252–254 (2004). https://doi.org/10.1007/s00404-003-0555-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-003-0555-0